低分子肝素治疗不稳定型心绞痛临床观察

目的 :观察低分子肝素 (速避凝 )治疗不稳定型心绞痛 ( UAP)的临床疗效。方法 :将 6 4例 U AP患者随机分为常规治疗组 (对照组 )及常规治疗加速避凝组 (治疗组 ) ,疗程为 1周。结果 :1周后总有效率 :治疗组为93.75 % ,对照组为 6 8.75 % ( P <0 .0 5 ) ;观察 12周治疗组无一例发生急性心肌梗死 ,对照组 3例发生 ( 9.38% ) ;治疗组未发现明显不良反应。结论 :在常规治疗基础上加用速避凝 ,能更有效地控制心绞痛发作 ,减少心肌梗死发生率

Clinical observation of fraxiparine in the treating unstable angina pectoris

Objective:To observe clinical therapeutic effectiveness of Fraxiparine in the treating unstable angina pectoris.Method:64 cases of unstable angina pectoris were randomly allocated into the control group (of normal treatment) and treating group (normal treatment combined with Fraxiparine). The therapeutic course was one week.Result:The effective rate was 93.75 % in the treating group and 68.75 % in the control group after one week (P< 0.05 ). No acute myocardial infraction happened in the treating group. 3 cases had acute myocardial infraction in the control group ( 9.38 %). And the treating group had no obvious adverse reaction.Conclusion:Fraxiparine combind with normal treatment can control angina pectoris effectively and decrease incidence of myocardial infraction.